prompt1 : extract information from  breast pathology report. List the histological classification, i.e. type of cancer or DCIS, subtype, description of any necrosis, any mention of tumor infiltrating lymphocytes,  histological grade, nuclear grade,  lymphovascular invasion, calcification, receptor status, IHC and any other ancillary testing results.  List out and expand the main points.
prompt2 : The report is - page 1 / 1. copy No. Examination: Histopathological examination. Cost of diagnostic procedure. Gender: M. Material: Multiple organ resection - left breast With axillary tissues. Expected time of examination: up to 8 working days. Clinical diagnosis: Cancer of the left breast. Upper outer quad. Results of immunohistochemical examination: Estrogen receptors found in over 75% of neoplastic cell nuclei. Progesterone receptors found in over 75% of. neoplastic cell nuclei. HER2 protein stained with HercepTest™M by DAKO. Positive reaction in invasive cancerous cells ( Score = 3+. Compliance validateu. Macroscopic description: Left breast sized 17.5 x 14 x 3 cm removed along with axillary tissues sized 8 x 12 x 3 cm and a skin flap of 13 x 5 cm. Tumour sized. 3.5 x 2.5 x 2.0 cm found on the boundary of outer quadrants, located 4.7 cm from the lower boundary, 0.15 cm from the base and. 0.8 cm from the skin. Lymph nodes from 0.2 to 2.8 cm. Microscopic description: Carcinoma ductale invasivum (partim Carcinoma micropapillare) - NHG2 (3+2+2/11 mitoses/10 HPF - visual area: 0.55mm). Foci of carcinoma ductale in situ (DCIS) present within the tumour (micropapillary and cribrate type with medium nuclear atypia. Mamilla sine laesionibus). Glandular tissue showing gynaecomasthia. Axillary lymph nodes: Metastases et micrometastases carcinomatosae in lymphonodis (No XXV/XXVIII). Infiltratio capsulac lymphonodorum et telae. perinodalis. Histopathological diagnosis: Carcinoma ductale invasivum partim carcinoma micropapillare invasivum. Invasive ductal and partially micropapillar carcinoma. of the left breas). Metastases et micrometastases carcinomatosae in lymphonodis axillae (No XXV/XXVIII). Cancer metastases. and micrometastases in axillary lymph nodes (NHG2; pT2; pN3a). Compliance validated h.

expanded version (tokens=932) : 
 Here's a breakdown of the information from the breast pathology report:

- Histological classification: The breast cancer is invasive ductal carcinoma (IDC) with mixed micropapillary carcinoma, also known as carcinoma ductale invasivum partim carcinoma micropapillare invasivum.

- Subtype and description: The IDC contains foci of ductal carcinoma in situ (DCIS) that are micropapillary and cribriform types with medium nuclear atypia. 

- Necrosis: There is no mention of necrosis in the report.

- Tumor infiltrating lymphocytes: There is no information on tumor infiltrating lymphocytes in the report.

- Histological grade and nuclear grade: The IDC is classified as NHG2 (Nottingham Histologic Grade 2), which means it is moderately differentiated. The nuclear grade is reported as 3+2+2.

- Lymphovascular invasion: There is no mention of lymphovascular invasion in the report.

- Calcification: There is no mention of calcification in the report.

- Receptor status: The immunohistochemistry (IHC) testing showed positive results for estrogen receptors (ER) and progesterone receptors (PR) in over 75% of neoplastic cell nuclei. HER2 protein stained with HercepTest™M by DAKO showed a positive reaction in invasive cancerous cells (Score = 3+).

- Ancillary testing results: No other

prompt : Please generate a succinct report in 75 words from the above information. Exclude any filler words or sentences. If something is not mentioned or specified, exclude it from the report. Low verbosity.

final output (tokens=1117) : 
 A 3.5 x 2.5 x 2.0 cm invasive ductal carcinoma (IDC) with mixed micropapillary carcinoma was found in the upper outer quadrant of a 17.5 x 14 x 3 cm left breast, with foci of ductal carcinoma in situ (DCIS). The IDC was moderately differentiated (NHG2) with a nuclear grade of 3+2+2. ER and PR were positive, and HER2 stained positive (Score = 3+) in invasive cancerous cells. There were metastases and micro-metastases in axillary lymph nodes (pT2; pN3a).

